Synthes/Mathys merger
This article was originally published in The Gray Sheet
Executive Summary
Synthes is "prepared to appeal" an anti-trust ruling prohibiting the German portion of its $1.1 bil. purchase of Mathys' osteosynthesis business, pending a "careful" analysis of the regulatory body's (Bundeskartellamt) decision, Synthes says March 29 (1"The Gray Sheet" Feb. 16, 2004, In Brief). The bulk of the Aug. 13 Mathys divestiture closed Feb. 6, excluding the German operations...